First steps for Bionomics' anti-anxiety drug
09 July, 2008 by Dylan Bushell-EmblingBionomics completes GMP synthesis of anxiety drug candidate
Extra indication for VivaGel
09 July, 2008 by Dylan Bushell-EmblingStarpharma to adapt VivaGel as bacterial vaginosis treatment
Brain Resource licenses behavioural health technology
08 July, 2008 by Dylan Bushell-EmblingReaches a three-year exclusive arrangement with OptumHealth
Positive results for Select
08 July, 2008 by Dylan Bushell-EmblingSelect Vaccines' bird flu candidate promising in pre-clinical trial
Phosphagenics appoints pharma veteran
08 July, 2008 by Dylan Bushell-EmblingMichael Ashton joins Phosphagenics' board
Prana co-founder addresses US Senate
08 July, 2008 by Dylan Bushell-EmblingRudolph Tanzi provides testimony on Alzheimer's in front of the Special Committee on Ageing
Somnomed finds UK distribution partner
08 July, 2008 by Dylan Bushell-EmblingSomnomed to distribute its snoring therapy to UK market through Intus Healthcare
ReCell approved in China
03 July, 2008 by Dylan Bushell-EmblingChinese SFDA approves Avita's ReCell for registration
Medical Therapies buys midkine IP
03 July, 2008 by Dylan Bushell-EmblingMedical Therapies concludes purchase of midkine protein IP
Safety first for device
02 July, 2008 by Dylan Bushell-EmblingSafety receives TGA cert for pen needle aid
ResMed addresses takeover rumours
01 July, 2008 by Dylan Bushell-EmblingClaims 'no comment' on rumours
ChemGenex on a roll
01 July, 2008 by Dylan Bushell-EmblingChemGenex completes first stage of FDA submission for omacetaxine
Unilife scores with sanofi-aventis
01 July, 2008 by Dylan Bushell-EmblingUnilife licenses ready-to-fill syringes in multimillion-dollar deal
